<DOC>
	<DOCNO>NCT00331500</DOCNO>
	<brief_summary>The purpose study demonstrate Olopatadine 0.2 % superior vehicle treatment sign symptom associate allergic conjunctivitis rhinoconjunctivitis .</brief_summary>
	<brief_title>Olopatadine 0.2 % Treatment Allergic Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<criteria>History seasonal allergic conjunctivitis rhinoconjunctivitis , positive grass antigen challenge reaction ( skin test ) , positive response grass Conjunctival Allergen Challenge ( CAC ) model Under 10 year age</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>